1.89
3.08%
-0.06
アフターアワーズ:
1.88
-0.01
-0.53%
前日終値:
$1.95
開ける:
$1.79
24時間の取引高:
51,789
Relative Volume:
0.09
時価総額:
$4.25M
収益:
-
当期純損益:
$-4.69M
株価収益率:
-0.5108
EPS:
-3.7
ネットキャッシュフロー:
$-3.81M
1週間 パフォーマンス:
-9.13%
1か月 パフォーマンス:
+2.16%
6か月 パフォーマンス:
-34.60%
1年 パフォーマンス:
-37.00%
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
名前
Lixte Biotechnology Holdings Inc
セクター
電話
310 203 2902
住所
248 ROUTE 25A, EAST SETAUKET
Lixte Biotechnology Holdings Inc (LIXT) 最新ニュース
LIXT stock touches 52-week low at $1.53 amid market challenges - Investing.com Australia
LIXT stock touches 52-week low at $1.53 amid market challenges By Investing.com - Investing.com South Africa
Lixte Biotechnology granted extension to meet Nasdaq listing rules By Investing.com - Investing.com Australia
Lixte Biotechnology granted extension to meet Nasdaq listing rules - Investing.com
Lixte Biotechnology Holdings Inc WT (LIXTW-Q) QuotePress Release - The Globe and Mail
Omeros (OMER) Shares Drop 5.04% Amid Financial Struggles - GuruFocus.com
MRVI Stock Drops 5.11% Amid Financial Report Release - GuruFocus.com
Lixte Biotechnology (NASDAQ:LIXT) Stock Price Down 2.1% - Defense World
LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy - GlobeNewswire
Should investors be concerned about LYT’s high price-to-sales ratio? - US Post News
Lilium (NASDAQ:LILM) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
Liquidia Co. (NASDAQ:LQDA) Shares Bought by Rhumbline Advisers - Defense World
Pacer Advisors Inc. Has $16.07 Million Stock Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World
Lipella Pharmaceuticals Inc’s Market Journey: Closing Weak at 0.41, Down -2.35 - The Dwinnex
Renaissance Technologies LLC Sells 2,000 Shares of LSI Industries Inc. (NASDAQ:LYTS) - Defense World
Texas Permanent School Fund Corp Trims Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World
First Eagle Investment Management LLC Increases Stake in LSI Industries Inc. (NASDAQ:LYTS) - Defense World
Huber Capital Management LLC Acquires 241,814 Shares of Lyft, Inc. (NASDAQ:LYFT) - Defense World
Acadian Asset Management LLC Cuts Position in LSI Industries Inc. (NASDAQ:LYTS) - Defense World
Quest Partners LLC Invests $28,000 in LSI Industries Inc. (NASDAQ:LYTS) - Defense World
Investors who lost money with shares of Liquidia Corporation - openPR
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia CorporationLQDA - Kilgore News Herald
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - Yahoo Finance
Biotech Steals The Show Following Pre-Clinical Data Announcement - MSN
Lixte Biotechnology Holdings Inc (LIXT) Stock: A Year of Decreases and Increases - The InvestChronicle
LIXTLixte Biotechnology Holdings, Inc. Latest Stock News & Market Updates - StockTitan
LIXTE Receives U.S. Patent Issue Notification for Immune Oncology - GlobeNewswire
Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) Short Interest Update - Defense World
Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Market Recap Check: Lixte Biotechnology Holdings Inc (LIXT)’s Positive Finish at 2.00, Up/Down 11.12 - The Dwinnex
LIXT Stock: A Voyage Through Lixte Biotechnology Holdings Inc’s Finances - The InvestChronicle
LIXT stock touches 52-week low at $1.55 amid market fluctuations - Investing.com
First Patient Dosed with LIXTE’s LB-100 in New Clinical - GlobeNewswire
First Patient Dosed with Lixte Biotechnology Holdings, Inc.?s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company - Marketscreener.com
First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company - StockTitan
Lixte Biotechnology faces Nasdaq delisting over equity shortfall - Investing.com India
LIXT (Lixte Biotechnology Holdings) PS Ratio : (As of Aug. 20, 2024) - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) PS Ratio : (As of Aug. 19, 2024) - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) Inventory-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com
LIXTE Biotechnology Provides Update On Recent Activities and Developments - ForexTV.com
LIXT (Lixte Biotechnology Holdings) Purchase Of Investment : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) Owner Earnings per Shar - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) COGS-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) Debt-to-Equity : 0.00 (As of Jun. 2024) - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) Effective Interest Rate on Debt % : 0.00% (As of Jun. 2024) - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) Effect of Exchange Rate Changes : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) Float Percentage Of Tot - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) Interest Coverage : 0 (At Loss) (As of Jun. 2024) - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) Capex-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) Receivables Turnover : 0.00 (As of Jun. 2024) - GuruFocus.com
LIXT (Lixte Biotechnology Holdings) Dividend Yield % : 0.00% (As of Aug. 16, 2024) - GuruFocus.com
Lixte Biotechnology Holdings Inc (LIXT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):